Viewing Study NCT01271764



Ignite Creation Date: 2024-05-05 @ 11:10 PM
Last Modification Date: 2024-10-26 @ 10:29 AM
Study NCT ID: NCT01271764
Status: COMPLETED
Last Update Posted: 2012-09-26
First Post: 2011-01-05

Brief Title: The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
Sponsor: Far Eastern Memorial Hospital
Organization: Far Eastern Memorial Hospital

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2012-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Tumor invasion and metastasis are the major causes of cancer-related death Some studies have found that histone methyltransferases such as EZH2 specifically affect metastasis in breast gastric and prostate cancer The functional roles of other members of the HMT family such as G9a in cancer remain obscure Therefore the investigators will investigate whether G9a have a role in recurrencemetastasis of endometrial cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None